This article is reserved for members

Already a member?

Log In

Not a member ?

Free registration
RLS Global to Submit Bankruptcy Application MT
RLS Global Abandons ChloraSolv Partnership with ConvaTec Group MT
RLS Global Launches Strategic Review of Options for ChloraSolv Commercialization MT
RLS Global Initiates Strategic Review Process Aiming to Commercialize ChloraSolv CI
RLS Global and Convatec Agree to Terminate Collaboration Agreement CI
RLS Global Enrols First Patient in Clinical Trial on Pressure Ulcers MT
RLS Global AB Announces First Patient Included in New Clinical Investigation on Pressure Ulcers CI
RLS Global AB Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023 CI
RLS Global Receives SEK5 Million Loan MT
RLS Global Names New CFO MT
RLS Global AB Announces Chief Financial Officer Changes CI
Cereno Scientific Names RLS Global CFO to Same Role MT
RLS Global AB Auditor Raises 'Going Concern' Doubt CI
RLS Global AB Reports Earnings Results for the First Quarter Ended March 31, 2023 CI
RLS Global AB Reports Earnings Results for the Fourth Quarter and Full Year Ended December 31, 2022 CI
RLS Global Chairman to Depart in February; Successor Nominated MT
Steve Krognes to Step Down as Chairman CI
RLS Global AB Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2022 CI
RLS Global To Issue New Shares To Pay Off Loan From Zebra Holdings MT
RLS Global AB Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2022 CI
RLS Global Names Observe Medical Exec As New CEO MT
RLS Global AB Introduces Chlorasolv in the Veterinary Care Segment in Scandinavia CI
Swedish Pharmaceutical Group RLS Global Taps Local Distributor In Middle East MT
RLS Global AB Reports Earnings Results for the First Quarter Ended March 31, 2022 CI
RLS Global CEO Resigns MT
Chart RLS Global AB (publ)
More charts
RLS Global AB, formerly OraSolv Products AB, is a Sweden-based company engaged in the development of dental care products. It is primarily engaged in the development of biochemical products and methods for minimally invasive dentistry. The Company's product portfolio includes Carisolv, a biochemical method for the removal of caries; Perisolv, product for the treatment of periodontitis; ChloraSolv, a treatment that cleanses and heals chronic wounds and Kindersolv, a caries treatment for children. The Company manufactures its products in the Sahlgrenska Science Park and sells them through distributors worldwide. The Company's main shareholders are Rls Global Intressenter AB, Joki Invest AB, Zebra Holdings and Investments Limited.
More about the company
  1. Stock Market
  2. Equities
  3. RLS Stock
  4. News RLS Global AB (publ)
  5. RLS Global Chairman to Depart in February; Successor Nominated